Difficulty: Medium
Average Score: 75%
Practice
Natalizumab is indicated in the treatment of refractory:
Correct answer
D
Rationale
Natalizumab, an anti-integrin antibody, is approved for refractory multiple sclerosis by reducing immune cell migration into the CNS.